Cell interactions with matrices via specific receptors control many functions, with chemistry, physics and membrane elasticity as fundamental elements of the processes involved. Little is known about how biochemical and biophysical processes integrate to generate force and, ultimately, to regulate hemopoiesis into the bone marrow-matrix environment. To address this hypothesis, in this work we focus on the regulation of megakaryocyte (MK) development by type I collagen. By atomic force microscopy analysis, we demonstrate that the tensile strength of fibrils in type I collagen structure is a fundamental requirement to regulate cytoskeleton contractility of human MKs through the activation of integrin alpha2beta1 dependent Rho-ROCK pathway and MLC-2 phosphorylation. Most importantly, this mechanism seemed to mediate MK migration, fibronectin assembly and platelet formation. On the contrary, decrease of mechanical tension caused by Nacetylation of lysine side chains in type I collagen, completely reverted these processes by preventing fibrillogenesis.
INTRODUCTION
Collagen fibrils are the main architectural element in several tissues and bones and the selfassembly processes involved in collagen fibrillogenesis are of enormous importance to matrix pathology and proper cell development. 1 Type I collagen plays a critical role, in the bone marrow niche environment, preventing platelet formation by megakaryocytes (MKs) through the activation of integrin alpha2beta1 and the Rho-ROCK pathway. 2, 3, 4 Changes in mechanical properties are tightly coupled in vivo to changes in matrix composition, crosslinking and density. 5 Moreover, different signalling pathways, related to the transduction of mechanical signals into biochemical responses, regulate cell behaviour. 6 However, the question on how biochemical and biophysical processes integrate to generate force and, ultimately, to regulate MK fate, is still open. Therefore, our purpose for the present work was to focus on MK function related to type I collagen organization and biomechanics.
METHODS
Type I collagen from bovine tendon was modified as previously described 9 and as reported in supplemental methods. Antibodies and solid phase binding assay are described in supplemental methods. MKs were differentiated from human cord blood progenitors as previously described as well as proplatelet and spreading assay, electron and immunofluorescence microscopy, Second
Harmonic Generation (SHG) and western blotting analysis. 4, 7, 8 Human cord blood was collected upon informed consent of the parents, with approval from the ethical committee of the IRCCS 
RESULTS AND DISCUSSION
The relationships between MK and bone marrow components are key factors in platelet formation.
Importantly, changes in mechanical properties are pervasive in vivo during pathological processes such as fibrosis or tumorigenesis. 11 Based on insight from the literature as well as from our prior studies, 7 we aimed to interrogate the synergy between biochemical and biophysical processes related to MK development within the bone marrow environment. To pursue this goal, we used a chemically modified type I collagen by N-acetylation of lysine side chains which blocks the formation of banded fibrils in neutral conditions ( Figure 1A ). Overall these data demonstrated, for the first time, that decreasing type I collagen stiffness along with a non-organized fibrillar structure completely reverted type I collagen-dependent functions of human MKs. Consistently, only stiffer native type I collagen, and not the N-acetylated one, was able to refrain MK migration ( Figure 2D ). These data demonstrated that type I collagen fibrils provide structural cues for MK adhesion and migration. 13 To further demonstrate that MKs anchored more strongly to stiffer type I collagen than to the softer N-acetylated one, we took advantage of our recent data on fibronectin (FN) as a mediator of MK adhesion to type I collagen. 8 Binding of FN to native and N-acetylated collagen was preserved as verified in solid-phase assays (Supplemental Figure 1) . Nevertheless, we demonstrated that only adhesion on fibrillar type I collagen led to the assembly of FITC-labeled FN in insoluble matrix on MK surface ( Figure 2E ) as well as to stable relocation to the plasma membrane of endogenous FN ( Figure 2F) . Figure 2H) . Interestingly, engagement of GPVI was shown by Src and Syk phosphorylation and no differences were observed upon adhesion on either collagen preparations ( Figure 2H ). Overall our results demonstrated that engagement of integrin alpha2beta1 is not sufficient to achieve the level of MLC-2 phosphorylation necessary to the inhibition of proplatelet normally exerted by fibrillar type I collagen. Further, GPVI activation in MKs seemed not to be affected by collagen structure and nano-mechanics. Therefore other, yet unknown, receptors may cooperate with alpha2beta1 to regulate MK function on type I collagen in a structure-dependent manner.
In conclusion, our results provide novel insight into the role of nano-mechanics of a bone marrow matrix-environment related to MK biology, leading to new concepts in understanding how MKs sense the stiffness and spatial patterning of their environment to modulate their function and fate.
The identifications of mechano-sensing receptors could be a novel approach to study MK behavior that deserve further investigations. Modification of matrix structure within bone marrow in a diseased state such as myelofibrosis may represent an important example of aberrant megakaryopoiesis dependent on alteration of bone marrow matrix nano-mechanics.
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